Sensus Healthcare announces the shipment of an SRT-100+ System to Cape Cod Hospital in Hyannis, Massachusetts, the second SRT-100+ System sold to a hospital in Massachusetts. This sale represents the Company’s ongoing success in the U.S. Northeast region as treating skin cancer with Sensus SRT technology continues to draw interest from community hospital oncology departments. Commenting on the sale, Joe Sardano, chairman and chief executive officer of Sensus Healthcare, said, “More and more hospitals around the country are inquiring about SRT as they consider making non- invasive skin cancer treatments available in their communities. It is becoming increasingly commonplace for hospitals to treat a larger population suffering with cancer on an outpatient basis, and our SRT systems offer an ideal non-surgical, painless and cosmetically appealing option while also helping hospitals to improve resource utilization.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on SRTS:
- Sensus Healthcare Sells Superficial Radiotherapy System to Cape Cod Hospital
- Sensus Healthcare to showcase full line of superficial radiotherapy devices
- Sensus Healthcare to Showcase its Full Line of Cutting-Edge Superficial Radiotherapy Devices for the Treatment of Non-melanoma Skin Cancer at ASTRO 2023 in San Diego
- Sensus Healthcare announces $3M share repurchase program
- Sensus Healthcare Announces New $3 Million Share Repurchase Program